| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 10681 | 2021 |
| Challenges in the development and establishment of exosome-based drug delivery systems J Wang, D Chen, EA Ho Journal of Controlled Release 329, 894-906, 2021 | 211 | 2021 |
| Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes J Gu, K Al-Bayati, EA Ho Drug delivery and translational research 7, 497-506, 2017 | 126 | 2017 |
| Nanoparticles encapsulated with LL37 and serpin A1 promotes wound healing and synergistically enhances antibacterial activity M Fumakia, EA Ho Molecular pharmaceutics 13 (7), 2318-2331, 2016 | 119 | 2016 |
| Regulation of multidrug resistance by pro-inflammatory cytokines EA Ho, M Piquette-Miller Current cancer drug targets 6 (4), 295-311, 2006 | 106 | 2006 |
| Drug release mechanism of paclitaxel from a chitosan–lipid implant system: Effect of swelling, degradation and morphology PL Soo, J Cho, J Grant, E Ho, M Piquette-Miller, C Allen European Journal of Pharmaceutics and Biopharmaceutics 69 (1), 149-157, 2008 | 91 | 2008 |
| In vitro and in vivo characterization of a novel biocompatible polymer–lipid implant system for the sustained delivery of paclitaxel EA Ho, V Vassileva, C Allen, M Piquette-Miller Journal of controlled release 104 (1), 181-191, 2005 | 82 | 2005 |
| Biodegradable film for the targeted delivery of siRNA-loaded nanoparticles to vaginal immune cells J Gu, S Yang, EA Ho Molecular pharmaceutics 12 (8), 2889-2903, 2015 | 78 | 2015 |
| Advancements in the field of intravaginal siRNA delivery S Yang, Y Chen, R Ahmadie, EA Ho Journal of controlled release 167 (1), 29-39, 2013 | 66 | 2013 |
| Impact of intraperitoneal, sustained delivery of paclitaxel on the expression of P-glycoprotein in ovarian tumors EA Ho, PL Soo, C Allen, M Piquette-Miller Journal of controlled release 117 (1), 20-27, 2007 | 62 | 2007 |
| Characterization of cationic liposome formulations designed to exhibit extended plasma residence times and tumor vasculature targeting properties EA Ho, E Ramsay, M Ginj, M Anantha, I Bregman, J Sy, J Woo, ... Journal of pharmaceutical sciences 99 (6), 2839-2853, 2010 | 58 | 2010 |
| Microfluidic technology for antibacterial resistance study and antibiotic susceptibility testing: review and perspective N Qin, P Zhao, EA Ho, G Xin, CL Ren ACS sensors 6 (1), 3-21, 2020 | 57 | 2020 |
| Pharmacological effects of a C-phycocyanin-based multicomponent nutraceutical in an in-vitro canine chondrocyte model of osteoarthritis SE Martinez, Y Chen, EA Ho, SA Martinez, NM Davies Canadian Journal of Veterinary Research 79 (3), 241-249, 2015 | 52 | 2015 |
| Novel intravaginal nanomedicine for the targeted delivery of saquinavir to CD4+ immune cells S Yang, Y Chen, K Gu, A Dash, CL Sayre, NM Davies, EA Ho International journal of nanomedicine, 2847-2858, 2013 | 52 | 2013 |
| Doxorubicin nanoformulations on therapy against cancer: An overview from the last 10 years NA D'Angelo, MA Noronha, MCC Câmara, IS Kurnik, C Feng, VHS Araujo, ... Biomaterials advances 133, 112623, 2022 | 45 | 2022 |
| Sustainable materials for fused deposition modeling 3D printing applications JP Rett, YL Traore, EA Ho Advanced Engineering Materials 23 (7), 2001472, 2021 | 45 | 2021 |
| Reversibly pH-responsive polyurethane membranes for on-demand intravaginal drug delivery S Kim, Y Chen, EA Ho, S Liu Acta biomaterialia 47, 100-112, 2017 | 45 | 2017 |
| Design and development of pH-responsive polyurethane membranes for intravaginal release of nanomedicines S Kim, YL Traore, EA Ho, M Shafiq, SH Kim, S Liu Acta Biomaterialia 82, 12-23, 2018 | 40 | 2018 |
| Development of polyether urethane intravaginal rings for the sustained delivery of hydroxychloroquine Y Chen, YL Traore, A Li, KR Fowke, EA Ho Drug design, development and therapy, 1801-1815, 2014 | 37 | 2014 |
| Protein/peptide‐based entry/fusion inhibitors as anti‐HIV therapies: challenges and future direction M Fumakia, S Yang, J Gu, EA Ho Reviews in medical virology 26 (1), 4-20, 2016 | 35 | 2016 |
